Genetic Clues for Skin Cancer Therapies Schenectady NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

M GRANT, MD
(518) 371-3391
989 Route 146
Clifton Park, NY
LILIA KOSHNITSKY, MD
(518) 435-8360
400 Patroon Creek Boulevard
Albany, NY
Joel Mark Spiro, MD
518-463-3169
736 Madison Ave Ste 1
Albany, NY
Stewart Raymond Altmayer, MD
518-783-8780
711 Troy Schenectady Rd Ste 211
Latham, NY
John A Brendese, MD
518-274-2030
2402 22nd St
Troy, NY
Stewart Altmayer
(518) 783-8780
711 Troy Schenectady Rd
Latham, NY
ROBERT SHOSS, MD
(518) 482-8631
2 Executive Park Drive
Albany, NY
John Andrew Carlson, MD
518-262-8500
47 New Scotland Ave Ste A24
Albany, NY
Barry David Goldman, MD
212-962-1115
20 June Dr
Albany, NY
Mitchell Scott Singer, MD
518-374-4400
1210 Union St
Schenectady, NY
Data Provided by:
    

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Filling in Wrinkles with Dermal Fillers Schenectady NY
In the summer, there are many different things that people like to do in order to have fun. Some people like to enjoy outdoor activities such as sports, while other people like to lie out in the sun for long periods of time and tan. Tanning is something that has become more and more popular amongst people since the early twentieth century, but too much tanning can lead to things like skin cancer and premature wrinkles.
- Healing Facial Spider Veins Schenectady NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Schenectady NY
- Breast Cancer Treatment Schenectady NY
- Getting a Botox Cosmetic Injection Schenectady NY
- Risk Factors for Squamous Cell Cancer of the Skin Schenectady NY
- Delayed Prostate Cancer Therapy Schenectady NY
- Risks for Childhood Cancer Survivors Schenectady NY
- Gene Mutation in Dogs Schenectady NY
- Follow Up After Skin Cancer Schenectady NY